Cashu | Summary

DJI

+0.15%

SPX

+0.36%

IXIC

+0.63%

FTSE

-0.42%

N225

+0.73%

AXJO

+0.22%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.15%

SPX

+0.36%

IXIC

+0.63%

FTSE

-0.42%

N225

+0.73%

AXJO

+0.22%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

760.37M

Dividend Yield

0.00%

P/E Ratio

182.56

EPS

0.14

Revenue

105.76M

Avg. Volume

115.13K

About

What does GYRE do?

Gyre Therapeutics, a San Diego-based biopharmaceutical company with 593 employees, focuses on developing F351 for treating NASH-associated fibrosis and has a pipeline through its indirect interest in Gyre Pharmaceuticals. The company went public on April 12, 2006, and also offers the drug ETUARY.

Sector

💻 Health Care

IPO

CEO

Employees

579

Headquarters

California, USA

Website

http://www.catalystbiosciences.com